TYNDALL JOSEPH A. bought AXGN
June 19, 2025 · Form 4 insider transaction
TYNDALL JOSEPH A. bought 14,150 shares of Axogen, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
14,150
Price
$0.00
Total value
N/A
InsiderTYNDALL JOSEPH A.
Role—
CompanyAxogen, Inc. (AXGN)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJune 19, 2025
Filing dateJune 20, 2025
Shares owned after14,150
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.; Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.